Genosys signs pact with IriSys in connection with Genosys' nitric oxide generator

By Ted A. Knutson

Washington, Jan. 31 - Genosys, Inc. announced Tuesday it has signed an agreement with IriSys, Inc. of San Diego to support the development of sufficient quantity and purity of nitric oxide using Genosys' portable generating device.

The contractor will further develop processes for manufacturing stable product and packaging methods using suitable components required for a Food and Drug Administration-required Investigational New Drug application.

"This contract represents a significant step toward our vision of making cost effective portable nitric oxide production a reality. We look forward to announcing additional strategic events in the near future," Clark Mower, Genosys' director, said in a news release.

Based in Provo, Utah, Genosys develops generic and specific gas-generating devices used for medical and laboratory purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.